Ibogaine is a powerful plant-based drug being studied for addiction treatment, but it can cause dangerous heart rhythm problems. The FDA (the US drug regulator) won't approve any drug it considers too risky without strong safety evidence, and that evidence doesn't exist yet. This means people cannot legally access ibogaine as an approved medicine in the US anytime soon.
Ibogaine's QT-prolongation and cardiotoxicity make near-term FDA approval implausible; current activity is limited to derivative research and early-phase work. No NDA decision is pending. Approval would appear on the FDA approvals database.